title: Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.
abstract: The generally accepted model for human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein topology includes a single membrane-spanning domain. An alternate model has been proposed which features multiple membrane-spanning domains. Consistent with the alternate model, a high percentage of HIV-1-infected individuals produce unusually robust antibody responses to a region of envelope, the so-called "Kennedy epitope," that in the conventional model should be in the cytoplasm. Here we show analogous, robust antibody responses in simian immunodeficiency virus SIVmac239-infected rhesus macaques to a region of SIVmac239 envelope located in the C-terminal domain, which in the conventional model should be inside the cell. Sera from SIV-infected rhesus macaques consistently reacted with overlapping oligopeptides corresponding to a region located within the cytoplasmic domain of gp41 by the generally accepted model, at intensities comparable to those observed for immunodominant areas of the surface component gp120. Rabbit serum raised against this highly immunogenic region (HIR) reacted with SIV envelope in cell surface-staining experiments, as did monoclonal anti-HIR antibodies isolated from an SIVmac239-infected rhesus macaque. However, control experiments demonstrated that this surface staining could be explained in whole or in part by the release of envelope protein from expressing cells into the supernatant and the subsequent attachment to the surfaces of cells in the culture. Serum and monoclonal antibodies directed against the HIR failed to neutralize even the highly neutralization-sensitive strain SIVmac316. Furthermore, a potential N-linked glycosylation site located close to the HIR and postulated to be outside the cell in the alternate model was not glycosylated. An artificially introduced glycosylation site within the HIR was also not utilized for glycosylation. Together, these data support the conventional model of SIV envelope as a type Ia transmembrane protein with a single membrane-spanning domain and without any extracellular loops.
authors.affiliation: New England Primate Research Center, Department of Microbiology and Immunobiology, Harvard Medical School, Southborough, Massachusetts, USA.
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Postler
authors.forename: José M
authors.initials: JM
authors.lastname: Martinez-Navio
authors.forename: Eloísa
authors.initials: E
authors.lastname: Yuste
authors.forename: Ronald C
authors.initials: RC
authors.lastname: Desrosiers
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D002462:Cell Membrane / Q000821:virology; D004195:Disease Models, Animal; D015686:Gene Products, env / Q000737:chemistry* / Q000235:genetics / Q000276:immunology*; D015483:HIV Antibodies / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000821:virology*; D015497:HIV-1 / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D006801:Humans; D008253:Macaca mulatta; D008969:Molecular Sequence Data; D017434:Protein Structure, Tertiary; D011817:Rabbits; D015682:Retroviridae Proteins, Oncogenic / Q000737:chemistry* / Q000235:genetics / Q000276:immunology*; D016415:Sequence Alignment; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000821:virology*; D015302:Simian Immunodeficiency Virus / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D014760:Viral Fusion Proteins / Q000737:chemistry* / Q000235:genetics / Q000276:immunology*
chemical_list: D015686:Gene Products, env; D015483:HIV Antibodies; D015682:Retroviridae Proteins, Oncogenic; D014760:Viral Fusion Proteins; C059580:transmembrane protein, Simian immunodeficiency virus
references.citation: J Biol Chem. 2007 Jan 19;282(3):2081-90
references.pmid: 17114808
references.citation: J Biol Chem. 1996 Sep 27;271(39):24201-6
references.pmid: 8798662
references.citation: J Virol. 1987 Jun;61(6):2024-8
references.pmid: 2437327
references.citation: Traffic. 2000 Aug;1(8):661-74
references.pmid: 11208154
references.citation: Adv Immunol. 2001;77:195-262
references.pmid: 11293117
references.citation: J Mol Biol. 2004 May 28;339(2):471-9
references.pmid: 15136048
references.citation: N Engl J Med. 1996 Jul 25;335(4):233-41
references.pmid: 8657239
references.citation: PLoS One. 2010 Dec 07;5(12):e15261
references.pmid: 21151874
references.citation: J Virol. 2003 Sep;77(18):9993-10003
references.pmid: 12941910
references.citation: AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51
references.pmid: 1380261
references.citation: J Virol. 2004 May;78(10):5500-6
references.pmid: 15113929
references.citation: Virology. 2005 Jul 5;337(2):284-96
references.pmid: 15913700
references.citation: Nature. 1989 Jun 1;339(6223):385-8, 340
references.pmid: 2542797
references.citation: J Virol. 2009 Nov;83(22):11588-98
references.pmid: 19726514
references.citation: AIDS Res Hum Retroviruses. 1989 Feb;5(1):7-22
references.pmid: 2541749
references.citation: AIDS Res Hum Retroviruses. 1995 Mar;11(3):327-34
references.pmid: 7786579
references.citation: J Virol. 2008 Dec;82(24):12472-86
references.pmid: 18829751
references.citation: Intervirology. 1990;31(6):327-38
references.pmid: 1704000
references.citation: Science. 1986 Mar 28;231(4745):1556-9
references.pmid: 3006246
references.citation: J Biol Chem. 2008 Jun 13;283(24):16723-31
references.pmid: 18408000
references.citation: Retrovirology. 2010 Nov 30;7:100
references.pmid: 21118523
references.citation: J Virol. 2001 Oct;75(20):9601-12
references.pmid: 11559792
references.citation: AIDS Res Hum Retroviruses. 1987 Spring;3(1):95-105
references.pmid: 3304356
references.citation: Virology. 2003 Oct 25;315(2):362-72
references.pmid: 14585339
references.citation: Virology. 2000 Jan 5;266(1):66-78
references.pmid: 10612661
references.citation: J Biol Chem. 1995 Jun 23;270(25):15336-40
references.pmid: 7797521
references.citation: J Gen Virol. 1992 Apr;73 ( Pt 4):951-4
references.pmid: 1378882
references.citation: J Gen Virol. 2005 Jan;86(Pt 1):131-138
references.pmid: 15604440
references.citation: J Gen Virol. 1990 Sep;71 ( Pt 9):1975-83
references.pmid: 2170568
references.citation: EMBO J. 1986 Nov;5(11):3065-71
references.pmid: 3466790
references.citation: AIDS Res Hum Retroviruses. 1993 Mar;9(3):197-8
references.pmid: 8471309
references.citation: Rev Med Virol. 2005 Nov-Dec;15(6):365-81
references.pmid: 16106492
references.citation: J Virol. 1999 Feb;73(2):1350-61
references.pmid: 9882340
references.citation: Biophys J. 2010 Nov 17;99(10):3438-44
references.pmid: 21081093
references.citation: N Engl J Med. 1985 Jan 31;312(5):265-70
references.pmid: 2981407
references.citation: J Immunol. 1995 Jul 1;155(1):473-88
references.pmid: 7602119
references.citation: Virology. 2000 Apr 25;270(1):1-3
references.pmid: 10772973
references.citation: J Virol. 1995 Sep;69(9):5217-27
references.pmid: 7636963
references.citation: J Biol Chem. 1997 Jul 18;272(29):18325-32
references.pmid: 9218473
references.citation: J Virol. 2005 Jul;79(13):8480-92
references.pmid: 15956591
references.citation: Virology. 1988 Jul;165(1):209-15
references.pmid: 2838959
references.citation: J Biol Chem. 2005 Oct 21;280(42):35352-60
references.pmid: 16046406
references.citation: J Infect Dis. 1986 Apr;153(4):736-42
references.pmid: 3005434
references.citation: Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6082-6
references.pmid: 2068087
references.citation: J Cell Biol. 1996 Mar;132(5):795-811
references.pmid: 8603913
references.citation: Nat Med. 1996 Aug;2(8):925-8
references.pmid: 8705864
references.citation: J Gen Virol. 2003 Mar;84(Pt 3):591-602
references.pmid: 12604810
references.citation: J Clin Invest. 1993 May;91(5):1987-96
references.pmid: 7683694
references.citation: Biochem J. 1999 Apr 15;339 ( Pt 2):269-79
references.pmid: 10191257
references.citation: Virology. 1997 Nov 24;238(2):305-15
references.pmid: 9400603
references.citation: Virology. 1995 Jan 10;206(1):713-7
references.pmid: 7530400
references.citation: Biopolymers. 1990 Jan;29(1):171-7
references.pmid: 2328285
references.citation: J Virol. 1997 Oct;71(10):7895-902
references.pmid: 9311879
references.citation: J Virol. 2008 Oct;82(19):9739-52
references.pmid: 18667507
references.citation: AIDS. 1991 Apr;5(4):425-30
references.pmid: 1647790
references.citation: J Infect Dis. 1992 Feb;165(2):256-61
references.pmid: 1370525
references.citation: J Biol Chem. 1993 Mar 15;268(8):5798-801
references.pmid: 8449946
references.citation: Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9871-5
references.pmid: 7568235
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):461-5
references.pmid: 1370580
references.citation: Methods. 2007 Apr;41(4):451-9
references.pmid: 17367717
references.citation: J Biol Chem. 1998 Jun 19;273(25):15773-8
references.pmid: 9624176
references.citation: J Virol. 1996 Jan;70(1):549-58
references.pmid: 8523568
references.citation: J Virol. 2004 Jul;78(13):6775-85
references.pmid: 15194752
references.citation: J Biol Chem. 1992 Apr 5;267(10):7121-7
references.pmid: 1551918